Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes
Clinical trial NCT03377335 · UNKNOWN
Trial details
- NCT number
- NCT03377335
- Sponsor
- University of Palermo
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2018-12-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.